22nd Century Group Inc.
The main focus of American company 22nd Century Group is the research, development, and production of low-nicotine smoking solutions. However, in conjunction with a wholly-owned subsidiary Botanical Genetics, they also have a license to supply patients with cannabinoid-based medicine. 22nd Century Group also owns Goodrich Tobacco Company, NASCO Products, and Heracles Pharmaceuticals.
The main focus of American company 22nd Century Group is the research, development, and production of low-nicotine smoking solutions. However, in conjunction with a wholly-owned subsidiary Botanical Genetics, they also have a license to supply patients with cannabinoid-based medicine. 22nd Century Group also owns Goodrich Tobacco Company, NASCO Products, and Heracles Pharmaceuticals.
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
XXII |
$1,572,904
|
100% |
$0.9700
|
